Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle
about
HIV-1 Vif, APOBEC, and intrinsic immunityAssociations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)Crystal Structure of the DNA Cytosine Deaminase APOBEC3F: The Catalytically Active and HIV-1 Vif-Binding DomainDifferent mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanismsT cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulationIdentification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.Stably expressed APOBEC3F has negligible antiviral activity.Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.The cellular source for APOBEC3G's incorporation into HIV-1.Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3GThe roles of APOBEC3G complexes in the incorporation of APOBEC3G into HIV-1.Positioning of APOBEC3G/F mutational hotspots in the human immunodeficiency virus genome favors reduced recognition by CD8+ T cellsSignals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment.Host restriction factors in retroviral infection: promises in virus-host interaction.HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes.Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.APOBEC3G subunits self-associate via the C-terminal deaminase domain.AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunityIdentification of a novel WxSLVK motif in the N terminus of human immunodeficiency virus and simian immunodeficiency virus Vif that is critical for APOBEC3G and APOBEC3F neutralization.Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteinsAPOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.Identification and characterization of loop7 motif and its role in regulating biological function of human APOBEC3G through molecular modeling and biological assay.The role of cytidine deaminases on innate immune responses against human viral infections.Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells.Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.Molecular Interactions of a DNA Modifying Enzyme APOBEC3F Catalytic Domain with a Single-Stranded DNA.Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature.HIV-1 Nef antagonizes SERINC5 restriction by downregulation of SERINC5 via the endosome/lysosome system.
P2860
Q24647833-1DC9340B-D2B1-4763-8800-4A902B67DAF4Q26781812-B5C7EE66-8C9C-4390-BC85-6A4146FA7E9AQ27678176-1DBBBFCD-1A9A-4BFB-9018-271DA8C5EE40Q28541264-AB4C7A02-8E1F-4E57-9898-7F487B77FCDFQ33300132-965B0E76-EDCC-41A6-AFF7-D8B103D87F0EQ33349452-B6A06EE9-BC13-479F-A95C-22AB0BC02732Q33654949-E4F768B3-70FF-42C9-A72E-C0F0CE84A898Q33825197-C7858F5B-9082-4158-B605-B222E2B8ABC5Q33877364-592CD856-9188-4CAA-85D2-E08BF1BA65D5Q33878087-478A700F-7496-4681-ADE9-C0EC30744672Q34055413-5065928F-F162-4E5D-B9A5-7D2E55F84A34Q34190587-77AFFF11-B83E-4F5D-B783-B04CAA869ABEQ34261416-D5E97B43-9613-4E7A-A86E-64FA988A28B9Q34506802-EF0DA4EC-779D-495C-A021-B7A6F53E0819Q34536866-84203256-1053-4516-B5C2-3909898FE432Q35009019-76A7F2B6-0743-4A08-8FDB-1D335CDB9990Q35145382-1F97EFBF-7EE1-44F4-9DC0-C616EEE16DCDQ35956555-B65A60DD-5061-49CA-8682-4AD174A2814DQ36156679-0EFC8C09-25DC-4F52-815F-FE8800D68B82Q36548179-C1971818-562B-449A-B62A-658DEBD9D442Q36677709-81FDF049-B302-4498-BD5E-BC0355D807EDQ36747707-56F83AA6-1E89-45E0-A0B8-30A798D2E53CQ36980981-2C78B422-D03E-446A-974D-D0D203BF524AQ37149767-84C62248-63C0-4239-8AE2-9A888A0EA3BFQ37333725-E4C992E6-7810-47FB-B263-80D0B9A97AD8Q37593180-1031E9AF-5881-48FA-9103-A565222C045EQ38610496-CC3EA326-7AA6-405A-8A5F-026DCF6295EEQ38629312-D3FFE498-DD68-4F40-9452-DFB6221EAABFQ40808215-E62467A4-D45C-43F3-BBC2-07DD3C576343Q41229652-1771D634-71B7-4B6D-A760-048BBEFF3BF2Q41812539-4B69DF02-526C-4071-ABA0-BA67EE98BDB5Q41890127-8D9081BE-512B-4838-B087-4DFBCEA065F5Q41892602-458473C9-E10B-49F5-85CE-6E4729A94DF8Q46172691-F6B6C9A2-AAA2-43C6-BB74-E3DE0A064201Q47555946-B963E7A8-CDA0-4AA1-8352-7713BBC52C66Q52668674-98BEFD47-B4D5-4E77-9FB3-08CA51BB7C70
P2860
Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@ast
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@en
type
label
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@ast
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@en
prefLabel
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@ast
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@en
P2860
P356
P1476
Biochemical differentiation of ...... sociated with HIV-1 life cycle
@en
P2093
Yong-Hui Zheng
P2860
P304
P356
10.1074/JBC.M610150200
P407
P577
2006-12-01T00:00:00Z